Literature DB >> 1533409

Tolerance induction in T helper (Th1) cells by thymic macrophages.

S Jayaraman1, Y Luo, M E Dorf.   

Abstract

Most macrophages in the peripheral tissues present Ag optimally to a variety of functionally distinct Th cells. Although thymic macrophages have been implicated in deleting autoreactive thymocytes, their role in influencing the functional capacities of mature T cells is not clear. We have established a normal untransformed macrophage cell line, named TMC, from the mouse thymus. The TMC line presents protein Ag to an IL-4-producing Th2 type Th clone after IFN-gamma treatment as evidence by T cell proliferation and the release of IL-3 and IL-4. However, these thymic macrophages are inefficient at stimulating a well characterized cytochrome C-specific IL-2-producing Th1 clone, A.E7. Ag presentation by TMC results in the production of IL-3 but not IL-2 production or proliferation of A.E7 cells. This selective Ag presentation defect to Th1 cells is corrected by the addition of live but not fixed allogeneic irradiated spleen cells, suggesting that the thymic macrophages lack the expression of costimulatory activity required for Th1 activation. This is further demonstrated by the failure of live thymic macrophages to provide costimulatory activity to A.E7 cells stimulated with fixed spleen cells plus the antigenic peptide 81-104. Exposure of A.E7 cells to paraformaldehyde-treated TMC in the presence of 81-104 peptide induces specific hyporesponsiveness, anergy. These data demonstrate that thymic macrophages can have a profound influence on the response of selected T cells to Ag. Furthermore, the nature of the T cell stimulus is also critical because Th1 and Th2 cells responded equally well to the T cell mitogen, Con A, and a bacterial superantigen presented by the thymic macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533409

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Development and characterization of a continuous macrophage cell line, LRTM, derived from thymus of Labeo rohita (Hamilton 1822).

Authors:  Sanjay C Rebello; Gaurav Rathore; Peyush Punia; Neeraj Sood; V Elangovan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-17       Impact factor: 2.416

2.  Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cells.

Authors:  C S Foster; A Rodriguez Garcia; M Pedroza-Seres; A Berra; A Heiligenhaus; S Soukiasian; S Jayaraman
Journal:  Trans Am Ophthalmol Soc       Date:  1993

Review 3.  Accessory cell-derived signals required for T cell activation.

Authors:  J G Johnson; M K Jenkins
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes.

Authors:  Sundararajan Jayaraman; Tejas Patel; Vasu Patel; Shahnaz Ajani; Rebecca Garza; Arathi Jayaraman; Sung Kwon; Rajvir Singh; Damiano Rondelli; Bellur S Prabhakar; Mark Holterman
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

5.  Antigen compartmentation and T helper cell tolerance induction.

Authors:  S Oehen; L Feng; Y Xia; C D Surh; S M Hedrick
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

6.  Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.

Authors:  S J Khoury; M H Sayegh; W W Hancock; L Gallon; C B Carpenter; H L Weiner
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

7.  Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.

Authors:  S J Khoury; L Gallon; W Chen; K Betres; M E Russell; W W Hancock; C B Carpenter; M H Sayegh; H L Weiner
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.